Across CKD stages and eGFR quartiles, anemic subjects generally had higher total FGF23 levels than non-anemic subjects, although statistical significance was not reached in all stages or quartiles (Supplemental Table 2). This evidence concerns the gene FGF23 and chronic kidney disease.